Indian CRO Licenses Columbia's PCR-Based Pathogen Detection Platform | GenomeWeb

NEW YORK (GenomeWeb News) - Columbia University said yesterday that it has licensed a pathogen-detection technology called MassTag PCR to Indian contract research and testing organization Vimta Labs.

Vimta will use the technology to develop clinical diagnostic products for patients in India, the university's technology transfer arm, Columbia Science and Technology Ventures, said in a statement.

MassTags are small chemical compounds of different molecular weights that are added to nucleotide primer sequences by an ultraviolet photocleaver linker, the STV said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.